✦ LIBER ✦

Response of vitiligo to once- vs. twice-daily topical tacrolimus: a controlled prospective, randomized, observer-blinded trial

✍ Scribed by S Radakovic; J Breier-Maly; R Konschitzky; H Kittler; P Sator; H Hoenigsmann; A Tanew

Book ID: 111095897
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 74 KB
Volume: 23
Category: Article
ISSN: 0926-9959
DOI: 10.1111/j.1468-3083.2009.03138.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A double-blind, randomized, placebo-cont

A double-blind, randomized, placebo-controlled trial of topical tacrolimus 0·1% vs. clobetasol propionate 0·05% in childhood vitiligo

✍ N. Ho; E. Pope; M. Weinstein; S. Greenberg; C. Webster; B.R. Krafchik 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 399 KB

Efficacy and safety of a new combination

Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial

✍ L. Guenther; F. Cambazard; P.C.M. Van De Kerkhof; E. Snellman; K. Kragballe; A. 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

## Background: Calcipotriol and betamethasone dipropionate are both widely used, effective treatments for psoriasis. vitamin d analogues and topical corticosteroids have different mechanisms of action in the treatment of psoriasis. a new vehicle has been developed in order to contain both calcipotr

Estimating number-needed-to-treat to avo

Estimating number-needed-to-treat to avoid hypoglycaemic episodes in people with type 2 diabetes: a post-hoc analysis of a prospective randomized controlled trial comparing once-daily insulin glargine with twice-daily NPH insulin

✍ Rosenstock, J.; Fonseca, V.; Dain, M.P.; Riddle, M. 📂 Article 📅 2009 🏛 Canadian Diabetes Association 🌐 English ⚖ 451 KB